Life science investor Syncona has announced that its newly-established portfolio company has entered into an agreement to buy the remaining stake in Freeline Th 22 November 2023
Portuguese contract development and manufacturing organization (CDMO) Hovione has acquired the start-up ExtremoChem for an undisclosed amount. 20 November 2023
A reverse merger will see two Massachusetts, USA-based companies, Q32 Bio and Homology Medicines (Nasdaq: FIXX), joining forces to focus on the former’s autoimm 20 November 2023
Vision-focused biopharma LENZ Therapeutics and Graphite Bio have entered into a definitive merger agreement to combine the companies in an all-stock transaction 16 November 2023
Markets have reacted warmly to a radical plan from Theseus Pharmaceuticals to cut costs and potentially put itself up for a sale or merger. 15 November 2023
Sign up to receive email updates Join industry leaders for a daily roundup of biotech & pharma news
Company Spotlight
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.